Notable Labs

Private

Clinical-stage precision oncology company that built a proprietary Predictive Precision Medicines Platform (PPMP) to bio-simulate cancer treatments and predict patient response. Originally tested combinations of FDA-approved drugs on patient cancer cell samples for blood cancers. Demonstrated 84% accuracy in predicting treatment responses with Stanford.

Company

Founded

2014

Headquarters

Foster City, United States

Financials

Total Funding

$66M

Sectors

Artificial Intelligence Biotech

notablelabs.com

Funding History

4 rounds

Undisclosed Feb 23, 2023

$10M

Builders VC B Capital Group Y Combinator First Round Capital Founders Fund

Series B Jul 16, 2019

$40M

B Capital Group (Lead) LifeForce Capital (Lead) Industry Ventures Castor Ventures Duro Ventures

Series A Sep 6, 2017

$10M

Builders VC (Lead) Eleven Two Capital First Round Capital Founders Fund Fuel Capital Lightspeed Venture Partners Upside Partnership Y Combinator

Seed Mar 24, 2015

$6M

Y Combinator Founders Fund First Round Capital Khosla Ventures AME Cloud Ventures DCVC OS Fund Refactor Capital Threshold Ventures Amasia

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.